4'-Fluoro-4-hydroxy[1,1'-biphenyl]-3-carbaldehyde, 96.0%, 5g

3-(tert-Butyl)-2-hydroxy-5-iodobenzaldehyde, 97%, 5g

(2-Aminopyridin-3-yl)(phenyl)methanone, 95.0%, 250mg

2-Bromo-9H-xanthen-9-one, 95.0%, 100g

3,7-Dibromonaphthalene-2,6-diol, 98%, 1g

Solución de sal disódica de EDTA, volumen ROTI® 0,01 mol/l - 0,01 N, ampolla, 1 pieza

5-Bromo-2-nitrobenzotrifluoride>98.0%(GC)5g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(perfluorophenyl)butanoic acid, 98%, 100mg

2-Amino-4,5-difluorobenzoic Acid>98.0%(HPLC)(T)25g

3-Piperazin-1-yl-benzo[d]isothiazole, 95.0%, 1g

phenyl(3-piperidinyl)methanone hydrochloride, 95.0%, 1g

3,7-Dibromodibenzo[b,d]furan, 95%, 5g

3-Hydroxy-2-nitropyridine>98.0%(GC)(T)25g